US Patent 7994272 Maleamic acid polymer derivatives and their bioconjugates
Patent 7994272 was granted and assigned to Nektar Therapeutics on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+300 characters)
Article
Patent abstract
The present invention is directed to maleamic acid derivatives of water soluble polymers, to chemically stable water-soluble polymer succinamic acid-active agent conjugates, and to methods for reproducibly preparing, characterizing and using such polymer reagents and their conjugates.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Antoni Kozlowski0
Remy F. Gross, III0
Samuel P. McManus0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07994272 Maleamic acid polymer derivatives and their bioconjugates US Patent 7994272 Maleamic acid polymer derivatives and their bioconjugates
Infobox
Patent Number
07994272
Patent Number
7994272
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07994272 Maleamic acid polymer derivatives and their bioconjugates
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07994272
Date of patent
August 9, 2011
Patent application number
12642413
Date Filed
December 18, 2009
Patent primary examiner
Find more entities like US Patent 7994272 Maleamic acid polymer derivatives and their bioconjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.